Lamivudine And Tenofovir Disoproxil Fumarate Tablets
Product Details:
- Pacakaging (Quantity Per Box) 30 tablets per box
- CAS No 134678-17-4 (Lamivudine) 202138-50-9 (Tenofovir Disoproxil Fumarate)
- Medicine Type Antiretroviral
- Expiration Date 24 months from the date of manufacture
- Dosage Form Tablets
- Grade Pharmaceutical Grade
- Molecular Formula Lamivudine (C8H11N3O3S) Tenofovir Disoproxil Fumarate (C19H30N5O10P·C4H4O4)
- Click to view more
X
Lamivudine And Tenofovir Disoproxil Fumarate Tablets Product Specifications
- Used for the treatment of HIV-1 infection in adults and adolescents
- Synthetic
- Lamivudine Tenofovir Disoproxil Fumarate
- White to off-white tablets
- Store below 30°C protect from light and moisture
- Lamivudine 300 mg + Tenofovir Disoproxil Fumarate 300 mg per tablet
- Taken orally as prescribed by a healthcare professional
- Not less than 98% purity for both active ingredients
- 134678-17-4 (Lamivudine) 202138-50-9 (Tenofovir Disoproxil Fumarate)
- 30 tablets per box
- 24 months from the date of manufacture
- Antiretroviral
- Lamivudine (C8H11N3O3S) Tenofovir Disoproxil Fumarate (C19H30N5O10P·C4H4O4)
- Tablets
- Pharmaceutical Grade
Other Products in 'HIV Medicine' category
Get in touch with us


